Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Berobenatide

VESPER-4

Pfizer · Phase 3 · Active, not recruiting · Enrollment 3578

NCT07311850

ArmPopulationDoseWeeksEstimandWeight change
MET097 Dose 1Obesity or overweightn/r84n/rn/r
MET097 Dose 2Obesity or overweightn/r84n/rn/r
MET097 Dose 3Obesity or overweightn/r84n/rn/r
PlaceboObesity or overweightn/r84n/rn/r